Skip to main content
AAN.com
Articles
July 27, 2011

Patient-ventilator asynchrony with nocturnal noninvasive ventilation in ALS

August 9, 2011 issue
77 (6) 549-555

Abstract

Background:

American Academy of Neurology (AAN) practice parameters for amyotrophic lateral sclerosis (ALS) include noninvasive positive pressure ventilation (NIV) for a forced vital capacity (FVC) ≤50%predicted. Despite the limited ability of NIV systems to deliver adequate ventilation synchronous with patient demand, nocturnal patient-ventilator asynchrony has not been systematically studied in patients with ALS prescribed such NIV.

Methods:

Twenty-three consecutively recruited patients with ALS reporting consistent use of nocturnal NIV (nNIV) prescribed for FVC ≤50% or orthopnea underwent home nocturnal polysomnography (PSG) on their current nNIV regimen (all used bilevel positive airway pressure). PSG recorded airflow, NIV pressures, thoracic and abdominal respiratory effort, and O2 saturation by pulse oximetry (SpO2). Patient-ventilator asynchrony was calculated as an asynchrony index (AI), the number of episodes of asynchrony per hour of nocturnal recording time (RT).

Results:

Nineteen patients had an adequate PSG. Their mean AI was 69 ± 46 SD (range 15–146/hour). Mean asynchrony time as a percent of RT was 17% ± 19%. Mean nadir SpO2 was 85% ± 7%. In multiple regression analysis, no demographic, functional severity (including FVC and ALS Revised Functional Rating Scale), or NIV (including pressure levels and duration of NIV prescription) variables were significantly predictive of degree of patient-ventilator asynchrony.

Conclusions:

These findings document frequent nocturnal patient-ventilator asynchrony in patients with ALS consistently using nNIV prescribed as per current AAN practice parameters, and suggest that use of nNIV per these parameters is unlikely to provide patients with ALS optimal nocturnal ventilatory support.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (figure_e-1.docm)
File (figure_e-2.docm)

REFERENCES

1.
Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Neurology 1999;52:1311–1323.
2.
Miller RG, Jackson CE, Kasarkis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218–1226.
3.
Pinto AC, Evangelista T, deCarvalho M, Alves MA, DeLurdes S, Luisqq ML. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurosci 1995;129 (suppl):19–26.
4.
Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of non-invasive positive pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127:450–453.
5.
Aboussouan LS, Khan SU, Banerjee M, Arrogiga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 2001;3:403–409.
6.
Farrero E, Prats E, Povedano M, Martinez-Matos JA, Manresa F, Escarrabill J. Survival in amyotrophic lateral sclerosis with home mechanical ventilation. Chest 2005;127:2132–2138.
7.
Carratu P, Spicuzza L, Cassano A, et al. Early treatment with noninvasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insufficiency. Orphanet J Rare Dis 2009;4:10.
8.
Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006;67:761–765.
9.
Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet 2006;5:140–147.
10.
Fanfulla F, Eugenia Taurino A, D'Artavilla Lupoa N, Trentin R, D'Ambrosio C, Nava S. Effect of sleep on patient/ventilator asynchrony in patients undergoing chronic non-invasive mechanical ventilation. Respir Med 2007;101:1702–1707.
11.
Vignaux L, Tassaux D, Jolliet P. Performance of noninvasive ventilation modes on ICU ventilators during pressure support: a bench model study. Intens Care Med 2007;33:1444–1451.
12.
Vignaux L, Vargas F, Roeseler J, et al. Patient-ventilator asynchrony during non-invasive ventilation for acute respiratory failure: a multicenter study. Intens Care Med 2009;35:840–846.
13.
Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124:96–107.
14.
Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659–664.
15.
Iber C, Ancoli-Israel S, Chesson A, Quan SF. for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications, 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
16.
Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function: BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13–21.
17.
Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005;64:38–43.
18.
Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and pulmonary function decline in patients with ALS. J Neurol Sci 1999;164:82–88.
19.
Lechtzin N, Rothstein J, Clawson L, Diette GB, Wiener CM. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment. Amyotroph Lat Scler Other Motor Neuron Dis 2002;3:5–13.
20.
Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler 2007;8:185–188.
21.
Gay PC, Westbrook PR, Daube JR, Litchy WJ, Windebank AJ, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc 1991;66:686–694.
22.
Ferguson KA, Strong MJ, Ahmad D, George CFP. Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest 1996;110:664–669.
23.
Pinto AC, Evangelista T, de Carvalho M, Paiva T, de Lurdes Sales-Luis ML. Respiratory disorders in ALS: sleep and exercise studies. J Neurol Sci 1999;169:61–68.
24.
Arnulf I, Similowski T, Salachas F, et al. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2000;161:849–856.
25.
Thille AW, Rodriguez P, Cabello B, et al. Patient-ventilator asynchrony during assisted mechanical ventilation. Intens Care Med 2006;32:1515–1522.
26.
Fanfulla F, Delmastro M, Berrdinelli A, Lupo ND, Nava S. Effects of different ventilator settings on sleep and inspiratory effort in patients with neuromuscular disease. Am J Respir Crit Care Med 2005;172:619–624.
27.
Guo YF, Sforza E, Janssens JP, et al. Respiratory patterns during sleep in obesity-hypoventilation patients treated with nocturnal pressure support: a preliminary report. Chest 2007;131:1090–1099.
28.
Ragette R, Mellies U, Schwake C, Voit T, Teschler H. Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002;57:724–728.
29.
Bye PT, Ellis ER, Issa FG, Donnelly PM, Sullivan CE. Respiratory failure and sleep in neuromuscular disease. Thorax 1990;45:241–247.
30.
Labanowski M, Schmidt-Nowara W, Guilleminault C. Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. Neurology 1997;49:1173–1180.
31.
Schettino G, Tucci M, Sousa R, Valente Barbas C, Passos Amato M, Carvalho C. Mask mechanics and leak dynamics during noninvasive pressure support ventilation: a bench study. Intens Care Med 2001;27:1887–1891.
32.
Parthasarathy S, Jubran A, Tobin MJ. Cycling of inspiratory and expiratory muscle groups with the ventilator in airflow limitation. Am J Respir Crit Care Med 1998;158:1471–1478.
33.
Gruis KL, Brown DL, Lisabeth LD, Zebarah VA, Chervin RD, Feldman EL. Longitudinal assessment of noninvasive positive pressure ventilation adjustments in ALS patients. J Neurol Sci 2006;247:59–63.
34.
Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory aids. Chest 2002;122:92–98.

Information & Authors

Information

Published In

Neurology®
Volume 77Number 6August 9, 2011
Pages: 549-555
PubMed: 21795658

Publication History

Received: January 11, 2011
Accepted: April 19, 2011
Published online: July 27, 2011
Published in print: August 9, 2011

Permissions

Request permissions for this article.

Disclosure

Dr. Atkeson performs polysomnography (40% effort) at the Cardiopulmonary Sleep and Ventilatory Disorders Center at Columbia University and receives research support from MDA/Wings Over Wall Street, the Will Rogers Institute, the ALS Association, and the Stony Wold Herbert Research Fund. Dr. RoyChoudhury receives research support from the Muscular Dystrophy Association, the NIH, and the Defense Threat Reduction Agency. G. Harrington-Moroney and Dr. Shah report no disclosures. Dr. Mitsumoto serves/has served on scientific advisory boards for Avanir Pharmaceuticals, Knopp Neurosciences Inc., Otsuka Pharmaceutical Co., Ltd., Neuralstem, Inc., and sanofi-aventis; and receives research support from Avanir Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knopp Neurosciences Inc., sanofi-aventis, the NIH (NINDS, NIEHS), the Muscular Dystrophy Association, MDA Wings Over Wall Street, and the Adams Foundation. Dr. Basner receives research support from the Will Rogers Institute, the ALS Association, the Stony-Wold Herbert Fund, and MDA/Wings Over Wall Street.

Authors

Affiliations & Disclosures

A.D. Atkeson, MD
From the Department of Medicine, the Cardiopulmonary Sleep and Ventilatory Disorders Center (A.D.A., B.S., R.C.B.), Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center (G.H.-M., H.M.), and Department of Biostatistics, Mailman School of Public Health (A.R.), Columbia University College of Physicians and Surgeons, New York, NY.
A. RoyChoudhury, PhD
From the Department of Medicine, the Cardiopulmonary Sleep and Ventilatory Disorders Center (A.D.A., B.S., R.C.B.), Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center (G.H.-M., H.M.), and Department of Biostatistics, Mailman School of Public Health (A.R.), Columbia University College of Physicians and Surgeons, New York, NY.
G. Harrington-Moroney, RN
From the Department of Medicine, the Cardiopulmonary Sleep and Ventilatory Disorders Center (A.D.A., B.S., R.C.B.), Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center (G.H.-M., H.M.), and Department of Biostatistics, Mailman School of Public Health (A.R.), Columbia University College of Physicians and Surgeons, New York, NY.
B. Shah, MD
From the Department of Medicine, the Cardiopulmonary Sleep and Ventilatory Disorders Center (A.D.A., B.S., R.C.B.), Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center (G.H.-M., H.M.), and Department of Biostatistics, Mailman School of Public Health (A.R.), Columbia University College of Physicians and Surgeons, New York, NY.
H. Mitsumoto, MD
From the Department of Medicine, the Cardiopulmonary Sleep and Ventilatory Disorders Center (A.D.A., B.S., R.C.B.), Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center (G.H.-M., H.M.), and Department of Biostatistics, Mailman School of Public Health (A.R.), Columbia University College of Physicians and Surgeons, New York, NY.
R.C. Basner, MD
From the Department of Medicine, the Cardiopulmonary Sleep and Ventilatory Disorders Center (A.D.A., B.S., R.C.B.), Department of Neurology, The Eleanor and Lou Gehrig MDA/ALS Research Center (G.H.-M., H.M.), and Department of Biostatistics, Mailman School of Public Health (A.R.), Columbia University College of Physicians and Surgeons, New York, NY.

Notes

Study funding: Supported by the MDA/Wings Over Wall Street.
Address correspondence and reprint requests to Dr. R.C. Basner, Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 622 West 168th Street, New York, NY 10032 [email protected]

Author Contributions

Dr. Atkeson: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, statistical analysis, study supervision, obtaining funding. Dr. RoyChoudhury: drafting/revising the manuscript, analysis or interpretation of data, statistical analysis. G. Harrington-Moroney: study concept or design, acquisition of data, study supervision. Dr. Shah: study concept or design, acquisition of data, study supervision. Dr. Mitsumoto: study concept or design, contribution of vital reagents/tools/patients, acquisition of data, study supervision. Dr. Basner: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, statistical analysis, study supervision, obtaining funding.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Sleep Disorders in Neuromuscular Diseases: A Narrative Review, Clinical and Translational Neuroscience, 7, 3, (23), (2023).https://doi.org/10.3390/ctn7030023
    Crossref
  2. Short-Term Effects of Pressure Controlled Versus Volume Controlled Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis, Respiratory Care, 66, 10, (1593-1600), (2021).https://doi.org/10.4187/respcare.09021
    Crossref
  3. Upper Airway Assessment and Responses During Mechanically Assisted Cough, Respiratory Care, 66, 7, (1196-1213), (2021).https://doi.org/10.4187/respcare.08960
    Crossref
  4. Respiratorische Ereigniserkennung unter nichtinvasiver Beatmung (NIV) in Abhängigkeit von der genutzten FlowmessungDetection of respiratory events under non-invasive ventilation (NIV) depending on the type of flow measurement, Somnologie, 24, 3, (159-167), (2020).https://doi.org/10.1007/s11818-020-00261-w
    Crossref
  5. Randomised controlled trial of polysomnographic titration of noninvasive ventilation, European Respiratory Journal, 53, 5, (1802118), (2019).https://doi.org/10.1183/13993003.02118-2018
    Crossref
  6. NIV in amyotrophic lateral sclerosis: The ‘when’ and ‘how’ of the matter, Respirology, 24, 6, (521-530), (2019).https://doi.org/10.1111/resp.13525
    Crossref
  7. Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, 7-8, (461-472), (2019).https://doi.org/10.1080/21678421.2019.1627372
    Crossref
  8. Sleep-Disordered Breathing in Neuromuscular and Chest Wall Diseases, Clinics in Chest Medicine, 39, 2, (309-324), (2018).https://doi.org/10.1016/j.ccm.2018.01.009
    Crossref
  9. Randomized cross‐over trial of ventilator modes during non‐invasive ventilation titration in amyotrophic lateral sclerosis, Respirology, 22, 6, (1212-1218), (2017).https://doi.org/10.1111/resp.13046
    Crossref
  10. What is in the Literature?, Journal of Clinical Neuromuscular Disease, 19, 2, (89-95), (2017).https://doi.org/10.1097/CND.0000000000000196
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share